news
Ivermectin found to suppresses tumour development
Researchers find ivermectin, a drug used to kill parasites, suppresses tumour development in epithelial ovarian cancer...
List view / Grid view
Anti-Cancer Therapeutics
news
Genetic fault reduces the effectiveness of leukaemia treatment
A genetic fault has been identified in people with an aggressive type of leukaemia that can significantly affect how they respond to treatment...
news
CYC065-eribulin combination for triple-negative breast cancer identified
Researchers find novel combination disrupts multiple factors in aggressive breast cancer...
news
Cancer drug stimulates tripolar mode of mitosis
Taxanes inhibit cell division and make cancer cells sensitive to radiation therapy, a current study has investigated the underlying mechanisms of this action...
news
Nivolumab superior to ipilimumab for adjuvant treatment of melanoma
Adjuvant nivolumab has been found to be more superior than ipilimumab in the standard of care in patients with surgically resected stage III/IV melanoma...
news
Zika virus shown to kill brain cancer stem cells
Research published in The Journal of Experimental Medicine suggests potential treatment for glioblastoma
news
Immunotherapy combination effective at killing cancer cells
Researchers have recently discovered an immunotherapy that uses existing cancer drugs in a whole new way...
news
Combination of conventional drugs enhances tumour cell death
Brazilian researchers have investigated whether cisplatin and 5-FU would interfere with the protein pRB...
news
Cancer Research UK launches trial to test new drug
A clinical trial to test a new cancer drug in patients with advanced solid tumours, launches in four centres across the UK...
news
Nexavar receives final appraisal for primary liver cancer
NICE has released a Final Appraisal Document recommending Nexavar for the treatment of patients with advanced hepatocellular carcinoma...
news
Gold nanoparticles raise hopes for cancer treatments
Researchers have discovered properties of the precious metal that allow catalytic abilities to be accessed in living things without any side effects...
news
FDA grants Breakthrough Therapy Designation status for acalabrutinib
It has been announced that the FDA has awarded AstraZeneca’s acalabrutinib product for MCL treatment Breakthrough Therapy Designation...
news
Imfinzi wins breakthrough therapy designation
AstraZeneca and MedImmune, have today announced that the US Food and Drug Administration has granted breakthrough therapy designation for Imfinzi for the treatment of patients with locally-advanced, unresectable non-small cell lung cancer...
news
Patients at risk as UK plans to leave Euratom
The UK's proposed withdrawal from Euratom may threaten the supply of essential medical isotopes, putting cancer patients at risk...
news
Uncovering the cause of immunotherapy resistance in tumours
Scientists have uncovered a key factor in the development of immunotherapy resistance in the case of cutaneous melanoma. This could potentially lead to future improvements in cancer therapy.
